đź“Š Evidence-Based Reference
raystation
Raysearch Laboratories Ab (Publ)
Summary: RayStation is a treatment planning system used in radiotherapy, primarily for proton and photon therapy. Key evidence highlights its integration capabilities and optimization functions.
FDA Clearance Information
Pathway
510K
Number
K171536 ↗
Decision Date
June 27, 2017
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
RayStation was cleared by the FDA through the 510(k) pathway on June 27, 2017. It is manufactured by Raysearch Laboratories Ab (Publ) and classified as a Class 2 device.
What It Is
RayStation is a comprehensive treatment planning system designed for radiotherapy. It supports advanced techniques such as proton and photon therapy, providing tools for dose calculation, optimization, and plan evaluation.
Clinical Applications
RayStation is commonly used in clinical scenarios involving complex radiotherapy planning, such as proton therapy for cancer treatment. It is utilized to enhance precision in dose delivery and optimize treatment outcomes.
Evidence Summary
The available literature includes 15 studies, comprising various study types such as RCTs and retrospective analyses, published between 2024 and 2026. These studies explore RayStation's integration, optimization, and simulation capabilities.
Reported Outcomes
Published studies report that RayStation enhances treatment planning quality through multi-criteria optimization and efficient auto-contouring. It facilitates accurate dose delivery in proton therapy and improves workflow integration with other systems.
Safety Profile
Reported complications include challenges in integrating RayStation with existing treatment planning systems, which may affect workflow efficiency. No direct adverse events related to patient safety were highlighted in the studies.
Evidence Limitations
The evidence is limited by the lack of long-term outcome data and direct comparisons with other treatment planning systems. Further research is needed to evaluate its impact on clinical outcomes and patient safety comprehensively.
Frequently Asked Questions
What are the clinical indications for RayStation?
RayStation is indicated for use in radiotherapy treatment planning, particularly in scenarios requiring precise dose calculations and optimization, such as proton and photon therapy.
What outcomes have been reported in clinical studies?
Studies have reported improved treatment planning quality and workflow efficiency, particularly in proton therapy, through the use of RayStation's optimization and auto-contouring features.
What complications have been reported?
Safety data indicate challenges in system integration, which may affect workflow, but no direct patient safety issues have been reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.